ID   PDE11_RAT               Reviewed;         935 AA.
AC   Q8VID6; Q8VID7; Q8VID8;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   24-JUL-2024, entry version 132.
DE   RecName: Full=Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A;
DE            EC=3.1.4.35 {ECO:0000269|PubMed:11502204};
DE            EC=3.1.4.53 {ECO:0000269|PubMed:11502204};
DE   AltName: Full=cAMP and cGMP phosphodiesterase 11A {ECO:0000303|PubMed:11502204};
GN   Name=Pde11a {ECO:0000303|PubMed:11502204, ECO:0000312|RGD:621793};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), FUNCTION, CATALYTIC
RP   ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY REGULATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=11502204; DOI=10.1046/j.1432-1327.2001.02366.x;
RA   Yuasa K., Ohgaru T., Asahina M., Omori K.;
RT   "Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A):
RT   comparison of rat and human PDE11A splicing variants.";
RL   Eur. J. Biochem. 268:4440-4448(2001).
CC   -!- FUNCTION: Plays a role in signal transduction by regulating the
CC       intracellular concentration of cyclic nucleotides cAMP and cGMP
CC       (PubMed:11502204). Catalyzes the hydrolysis of both cAMP and cGMP to
CC       5'-AMP and 5'-GMP, respectively (PubMed:11502204).
CC       {ECO:0000269|PubMed:11502204}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic GMP + H2O = GMP + H(+); Xref=Rhea:RHEA:16957,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57746,
CC         ChEBI:CHEBI:58115; EC=3.1.4.35;
CC         Evidence={ECO:0000269|PubMed:11502204};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic AMP + H2O = AMP + H(+); Xref=Rhea:RHEA:25277,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:58165,
CC         ChEBI:CHEBI:456215; EC=3.1.4.53;
CC         Evidence={ECO:0000269|PubMed:11502204};
CC   -!- COFACTOR:
CC       Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
CC         Evidence={ECO:0000250|UniProtKB:O76083};
CC       Note=Binds 2 divalent metal cations per subunit. Site 1 may
CC       preferentially bind zinc ions, while site 2 has a preference for
CC       magnesium and/or manganese ions. {ECO:0000250|UniProtKB:O76083};
CC   -!- ACTIVITY REGULATION: Inhibited by 3-isobutyl-1-methylxanthine (IBMX),
CC       zaprinast and dipyridamole. cGMP acts as an allosteric activator.
CC       {ECO:0000269|PubMed:11502204}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.9 uM for cAMP (isoform 1) {ECO:0000269|PubMed:11502204};
CC         KM=1.6 uM for cGMP (isoform 1) {ECO:0000269|PubMed:11502204};
CC         KM=4.0 uM for cAMP (isoform 2) {ECO:0000269|PubMed:11502204};
CC         KM=1.6 uM for cGMP (isoform 2) {ECO:0000269|PubMed:11502204};
CC         KM=2.2 uM for cAMP (isoform 3) {ECO:0000269|PubMed:11502204};
CC         KM=1.3 uM for cGMP (isoform 3) {ECO:0000269|PubMed:11502204};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q9HCR9}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=PDE11A4 {ECO:0000303|PubMed:11502204};
CC         IsoId=Q8VID6-1; Sequence=Displayed;
CC       Name=2; Synonyms=PDE11A3 {ECO:0000303|PubMed:11502204};
CC         IsoId=Q8VID6-2; Sequence=VSP_019903, VSP_019904;
CC       Name=3; Synonyms=PDE11A2 {ECO:0000303|PubMed:11502204};
CC         IsoId=Q8VID6-3; Sequence=VSP_019902, VSP_019905;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is expressed in brain, heart, kidney and
CC       liver, but not in prostate. Isoform 2 is specifically expressed in
CC       testis. Isoform 3 is expressed in various tissues including brain,
CC       lung, skeletal muscle, spleen, testis and prostate.
CC       {ECO:0000269|PubMed:11502204}.
CC   -!- DOMAIN: The tandem GAF domains bind cGMP, and regulate enzyme activity.
CC       The binding of cGMP stimulates enzyme activity.
CC       {ECO:0000250|UniProtKB:Q9HCR9}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB059360; BAB79627.1; -; mRNA.
DR   EMBL; AB059361; BAB79628.1; -; mRNA.
DR   EMBL; AB059362; BAB79629.1; -; mRNA.
DR   RefSeq; NP_001120952.1; NM_001127480.1. [Q8VID6-2]
DR   RefSeq; NP_001120953.1; NM_001127481.2. [Q8VID6-3]
DR   RefSeq; NP_543169.1; NM_080893.1. [Q8VID6-1]
DR   AlphaFoldDB; Q8VID6; -.
DR   SMR; Q8VID6; -.
DR   BioGRID; 250862; 1.
DR   STRING; 10116.ENSRNOP00000008300; -.
DR   iPTMnet; Q8VID6; -.
DR   PhosphoSitePlus; Q8VID6; -.
DR   PaxDb; 10116-ENSRNOP00000008300; -.
DR   Ensembl; ENSRNOT00000045862.3; ENSRNOP00000048657.2; ENSRNOG00000024457.7. [Q8VID6-3]
DR   Ensembl; ENSRNOT00000050355.4; ENSRNOP00000051289.1; ENSRNOG00000024457.7. [Q8VID6-2]
DR   Ensembl; ENSRNOT00065029752; ENSRNOP00065023634; ENSRNOG00065017777. [Q8VID6-1]
DR   GeneID; 140928; -.
DR   KEGG; rno:140928; -.
DR   AGR; RGD:621793; -.
DR   CTD; 50940; -.
DR   RGD; 621793; Pde11a.
DR   VEuPathDB; HostDB:ENSRNOG00000024457; -.
DR   eggNOG; KOG3689; Eukaryota.
DR   GeneTree; ENSGT00940000162151; -.
DR   HOGENOM; CLU_006980_0_1_1; -.
DR   InParanoid; Q8VID6; -.
DR   OrthoDB; 5479253at2759; -.
DR   PhylomeDB; Q8VID6; -.
DR   TreeFam; TF316499; -.
DR   Reactome; R-RNO-418457; cGMP effects.
DR   Reactome; R-RNO-418555; G alpha (s) signalling events.
DR   SABIO-RK; Q8VID6; -.
DR   PRO; PR:Q8VID6; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000024457; Expressed in testis and 8 other cell types or tissues.
DR   ExpressionAtlas; Q8VID6; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; IBA:GO_Central.
DR   GO; GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IBA:GO_Central.
DR   GO; GO:0030553; F:cGMP binding; ISO:RGD.
DR   GO; GO:0004118; F:cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; ISS:UniProtKB.
DR   GO; GO:0004112; F:cyclic-nucleotide phosphodiesterase activity; IDA:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019933; P:cAMP-mediated signaling; IBA:GO_Central.
DR   GO; GO:0043951; P:negative regulation of cAMP-mediated signaling; IDA:RGD.
DR   GO; GO:0010754; P:negative regulation of cGMP-mediated signaling; IDA:RGD.
DR   CDD; cd00077; HDc; 1.
DR   Gene3D; 3.30.450.40; -; 2.
DR   Gene3D; 1.10.1300.10; 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain; 1.
DR   InterPro; IPR003018; GAF.
DR   InterPro; IPR029016; GAF-like_dom_sf.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR036971; PDEase_catalytic_dom_sf.
DR   InterPro; IPR023174; PDEase_CS.
DR   PANTHER; PTHR11347; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; 1.
DR   PANTHER; PTHR11347:SF130; DUAL 3',5'-CYCLIC-AMP AND -GMP PHOSPHODIESTERASE 11A; 1.
DR   Pfam; PF01590; GAF; 2.
DR   Pfam; PF00233; PDEase_I; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SMART; SM00065; GAF; 2.
DR   SMART; SM00471; HDc; 1.
DR   SUPFAM; SSF55781; GAF domain-like; 2.
DR   SUPFAM; SSF109604; HD-domain/PDEase-like; 1.
DR   PROSITE; PS00126; PDEASE_I_1; 1.
DR   PROSITE; PS51845; PDEASE_I_2; 1.
PE   1: Evidence at protein level;
KW   Allosteric enzyme; Alternative splicing; cAMP; cGMP; Cytoplasm; Hydrolase;
KW   Metal-binding; Phosphoprotein; Reference proteome; Repeat.
FT   CHAIN           1..935
FT                   /note="Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase
FT                   11A"
FT                   /id="PRO_0000247042"
FT   DOMAIN          217..370
FT                   /note="GAF 1"
FT   DOMAIN          402..558
FT                   /note="GAF 2"
FT   DOMAIN          588..912
FT                   /note="PDEase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01192"
FT   REGION          41..125
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          915..935
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        664
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   BINDING         424
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /evidence="ECO:0000250|UniProtKB:Q922S4"
FT   BINDING         668
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01192"
FT   BINDING         704
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01192"
FT   BINDING         705
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01192"
FT   BINDING         705
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01192"
FT   BINDING         816
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01192"
FT   MOD_RES         162
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P0C1Q2"
FT   MOD_RES         163
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P0C1Q2"
FT   MOD_RES         239
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HCR9"
FT   VAR_SEQ         1..354
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11502204"
FT                   /id="VSP_019902"
FT   VAR_SEQ         1..250
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11502204"
FT                   /id="VSP_019903"
FT   VAR_SEQ         251..304
FT                   /note="KTLVSKFFDVHAGTPLLPCSTTENSNEVQVPWGKGIIGYVGEHGETVNIPDA
FT                   YQ -> MLKQARRFSFRNVRSATQWRKVGSTRQGQISGAFLAERLDKHQDFLTRMQTRT
FT                   K (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11502204"
FT                   /id="VSP_019904"
FT   VAR_SEQ         355..357
FT                   /note="DEK -> MSW (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11502204"
FT                   /id="VSP_019905"
SQ   SEQUENCE   935 AA;  104571 MW;  E80F1039770F8276 CRC64;
     MAASRLDFGE VETFLDRHPE LFEDYLMRKG KQELVDKWLQ RHSSGQGASD LRPALAGASS
     LAQSSARGST GIGGGAGPQG SANSHPASGG GESAGVPLSP SWASGSRGDG NLQRRASQKE
     LRKSFARSKA IHVNRTYDEQ VTSRAQEPLS SVRRRALLRK ASSLPPTTAH ILSALLESRV
     NLPQYPPTAI DYKCHLKKHN ERQFFLELVK DISNDLDLTS LSYKILIFVC LMVDADRCSL
     FLVEGAAAGK KTLVSKFFDV HAGTPLLPCS TTENSNEVQV PWGKGIIGYV GEHGETVNIP
     DAYQDRRFND EIDKLTGYKT KSLLCMPIRN SDGEIIGVAQ AINKVPEGAP FTEDDEKVMQ
     MYLPFCGIAI SNAQLFAASR KEYERSRALL EVVNDLFEEQ TDLEKIVKKI MHRAQTLLKC
     ERCSVLLLED IESPVVKFTK SFELMSPKCS ADAENSFKES VEKSSYSDWL INNSIAELVA
     STGLPVNVSD AYQDPRFDAE ADQISGFHIR SVLCVPIWNS NHQIIGVAQV LNRLDGKPFD
     DADQRLFEAF VIFCGLGINN TIMYDQVKKS WAKQSVALDV LSYHATCSKA EVDKFKAANI
     PLVSELAIDD IHFDDFSLDV DAMITAALRM FMELGMVQKF KIDYETLCRW LLTVRKNYRM
     VLYHNWRHAF NVCQLMFAML TTAGFQEILT EVEILAVIVG CLCHDLDHRG TNNAFQAKSD
     SALAQLYGTS ATLEHHHFNH AVMILQSEGH NIFANLSSKE YSDLMQLLKQ SILATDLTLY
     FERRTEFFEL VSKGAYDWSI TSHRDVFRSM LMTACDLGAV TKPWEISRQV AELVTSEFFE
     QGDRERSELK LTPSAIFDRN RKDELPRLQL EWIDSICMPL YQALVKVNAK LKPMLDSVAA
     NRRKWEELHQ KRLQVSAASP VPSSPSPAVA GEDRL
//
